NCT04461236View on ClinicalTrials.gov

Isoleucine Intake and Intermediary Metabolism in Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

May 30, 2019

Primary Completion Date

March 2, 2020

Study Completion Date

March 2, 2020

Conditions
Type 2 Diabetes
Interventions
DIETARY_SUPPLEMENT

Oral Supplement

Supplement provided in capsules. Half the capsules to be taken with lunch and the other half with dinner. All supplements are commercially available.

DIETARY_SUPPLEMENT

Placebo

Placebo

Trial Locations (1)

77845-4253

Texas A&M University CTRAL, College Station

All Listed Sponsors
lead

Texas A&M University

OTHER

NCT04461236 - Isoleucine Intake and Intermediary Metabolism in Type 2 Diabetes | Biotech Hunter | Biotech Hunter